← Open Payments lookup

IMTIAZUDDIN SIDDIQUI: Open Payments

NPI 1851477186 · WAYNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$360 in 22 payments from 8 companies in 2025. Trend: 2023 $37 · 2024 $261 · 2025 $360

Food & beverage: $360
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.11$168
Neurocrine BioSciences, Inc.2$40
Janssen Pharmaceuticals, Inc2$33
Teva Pharmaceuticals USA, Inc.2$32
Otsuka America Pharmaceutical, Inc.2$30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$23
Alkermes, Inc.1$20
Vanda Pharmaceuticals Inc.1$14

Products named: COBENFY, INGREZZA, INVEGA SUSTENNA, UZEDY, CAPLYTA, ARISTADA, ABILIFY ASIMTUFII, HETLIOZ.

Industry payments across NJ — which companies pay providers there.